22-Aug-2007 - GlaxoSmithKline (GSK) and Merck Sharp & Dohme (MSD) have made further moves in their plans to boost their presence in Singapore, a region growing in popularity for biopharmaceutical research and manufacture.
21-Aug-2007 - Pharmatek Laboratories has now added cytotoxic and high-potent drug development services to its list of contract pharmaceutical offerings.
16-Aug-2007 - Pfizer was taken by surprise this week as a US engineering firm announced that it had been awarded a contract to manage construction of the firm's proposed biotech production plant in Ireland, before the plant plans themselves have even been approved by internal Pfizer decision makers.
16-Aug-2007 - 'Legislative chaos' has been preventing Poland from reaching its full potential in the increasingly competitive central Eastern European (CEE) region, although progress is being made.
06-Aug-2007 - Asuragen has launched a newly expanded miRNA expression profiling service that can search over 13,000 human candidate miRNAs.
06-Aug-2007 - PharmaNet has reported second quarter results that place it back in the red after it had only just clawed its way back into the black in the first quarter, following a string of quarterly losses.
06-Aug-2007 - German pharma firm Stada has acquired Russian pharmaceuticals group Makiz in a deal worth up to €135m, giving the company a sturdy foothold in the growing Russian market and enhanced in-house production capacity.
02-Aug-2007 - MDS Pharma Services has announced it is expanding its development and regulatory services (DRS) business in Europe while its bioanalytical operations are still struggling.
30-Jul-2007 - Akorn, Dompé, Angel Biotech and Flamingo Pharmaceuticals have all made new contract manufacturing announcements this past week.
17-Jul-2007 - US biopharmaceutical company VGX has strengthened its position in the plasmid DNA area with the award of two new patents covering the use and manufacture of plasmid DNA.
10-Jul-2007 - Contract manufacturing organisation (CMO) Angel Biotechnology has penned a brand new deal with a Russian drug maker worth £450,000 (€664,000) just a few days after closing its struggling UK facility.
04-Jul-2007 - Agilent, Goodwin Biotechnology, IntegrityBio, Vastox, and AMRI have all made new contract manufacturing announcements this past week.
04-Jul-2007 - NPS Pharmaceuticals has sold two facilities and appointed a new COO as part of a recently revealed restructuring strategy to rely more on outsourcing.
04-Jul-2007 - New research provides some insight into what motivates patients to participate in clinical trials and how the experience could be improved for them.
03-Jul-2007 - PharmaNet Development Group has reached a significant turning point in its attempt to finally close the doors on a long period of trouble with its Phase I clinical business.
03-Jul-2007 - British contract manufacturing organisation (CMO) NextPharma Technologies has announced a €30m fundraising round and the acquisition of Bioserv, another CMO based in the US.
02-Jul-2007 - AstraZeneca has sold a manufacturing plant in France to a contract manufacturer who will continue to supply the drug giant with its products under a new outsourcing contract.
28-Jun-2007 - Aptuit Laurus, the newly formed joint venture between Aptuit and Laurus Labs in India, will focus on an expected rise in the demand for preclinical and Phase I research and development services as part of its growth plan in India.
27-Jun-2007 - Asterand said it is to slash 10 per cent of its total workforce in a cost-cutting strategy although it is not a knock-on effect of the recent ban on export of human samples from Russia.
27-Jun-2007 - Procter & Gamble (P&G) has announced its intention to outsource the active pharmaceutical ingredient (API) R&D and manufacturing work undertaken at one of its US factories, with resultant closure of the site and job losses.
25-Jun-2007 - Parexel talks to Outsourcing-Pharma about Phase I trials, touching on trends and growth opportunities, future plans for India and lessons learned from Tegenero.
20-Jun-2007 - Despite a lift of the ban on biological sample transportation out of Russia, the country's clinical research industry is still in the dark on the new rules to control export of such materials.
14-Jun-2007 - Nicholas Piramal India (NPIL) has opened its second clinical research facility and is eyeing the growing area of biopharmaceutical testing.
13-Jun-2007 - Pfizer is to plough $300m (€226m) into South Korean research and development over the next five years, while it's CEO is planning to visit North Korea tomorrow.
12-Jun-2007 - Asterand has announced a restructure and changes to its operational model in a bid to grasp hold of profitability.